ATE255593T1 - Peptide und medikamente für knochenkrankheiten welche diese peptide als aktive bestandteile beinhalten - Google Patents

Peptide und medikamente für knochenkrankheiten welche diese peptide als aktive bestandteile beinhalten

Info

Publication number
ATE255593T1
ATE255593T1 AT96908335T AT96908335T ATE255593T1 AT E255593 T1 ATE255593 T1 AT E255593T1 AT 96908335 T AT96908335 T AT 96908335T AT 96908335 T AT96908335 T AT 96908335T AT E255593 T1 ATE255593 T1 AT E255593T1
Authority
AT
Austria
Prior art keywords
peptides
peptide
drugs
contain
active ingredients
Prior art date
Application number
AT96908335T
Other languages
English (en)
Inventor
Kenji Sakamoto
Original Assignee
Sakamato Kenji
Nakoshi Hideo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sakamato Kenji, Nakoshi Hideo filed Critical Sakamato Kenji
Application granted granted Critical
Publication of ATE255593T1 publication Critical patent/ATE255593T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT96908335T 1995-04-03 1996-04-03 Peptide und medikamente für knochenkrankheiten welche diese peptide als aktive bestandteile beinhalten ATE255593T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10168195A JP3398255B2 (ja) 1995-04-03 1995-04-03 新規ペプチド及びそれを有効成分とする骨疾患治療薬
PCT/JP1996/000915 WO1996031530A1 (fr) 1995-04-03 1996-04-03 Nouveaux peptides et medicaments pour les maladies osseuses contenant ces peptides comme ingredient actif

Publications (1)

Publication Number Publication Date
ATE255593T1 true ATE255593T1 (de) 2003-12-15

Family

ID=14307095

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96908335T ATE255593T1 (de) 1995-04-03 1996-04-03 Peptide und medikamente für knochenkrankheiten welche diese peptide als aktive bestandteile beinhalten

Country Status (10)

Country Link
US (2) US6420520B1 (de)
EP (1) EP0821004B1 (de)
JP (1) JP3398255B2 (de)
KR (1) KR19980703527A (de)
CN (1) CN1142178C (de)
AT (1) ATE255593T1 (de)
AU (1) AU5162196A (de)
BR (1) BR9604843A (de)
DE (1) DE69630948T2 (de)
WO (1) WO1996031530A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3398255B2 (ja) * 1995-04-03 2003-04-21 賢二 坂本 新規ペプチド及びそれを有効成分とする骨疾患治療薬
JP3459523B2 (ja) * 1996-10-02 2003-10-20 賢二 坂本 生理活性物質の製造方法
ES2359645T3 (es) 2005-08-12 2011-05-25 Riken Glucoproteína de tipo mucina y su uso.
KR101957581B1 (ko) * 2017-02-08 2019-03-13 부경대학교 산학협력단 홍합단백질 유래 펩타이드를 유효성분으로 포함하는 골질환의 예방 또는 치료용 조성물
WO2018147517A1 (ko) * 2017-02-08 2018-08-16 부경대학교 산학협력단 꼬막단백질 유래 펩타이드를 유효성분으로 포함하는 골질환의 예방 또는 치료용 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262319A (en) 1985-04-19 1993-11-16 Oncogene Science, Inc. Method for obtaining bone marrow free of tumor cells using transforming growth factor β3
MX9204303A (es) * 1991-07-23 1993-11-01 Rhone Poulenc Rorer Int Factor regulador del crecimiento de osteoclasto.
JP3398255B2 (ja) * 1995-04-03 2003-04-21 賢二 坂本 新規ペプチド及びそれを有効成分とする骨疾患治療薬
US6071881A (en) * 1996-04-03 2000-06-06 Sakamoto; Kenji Peptides and remedy for bone diseases containing the same as active ingredient

Also Published As

Publication number Publication date
JPH08269091A (ja) 1996-10-15
EP0821004A1 (de) 1998-01-28
US20040162415A1 (en) 2004-08-19
WO1996031530A1 (fr) 1996-10-10
EP0821004B1 (de) 2003-12-03
US6930091B2 (en) 2005-08-16
CN1142178C (zh) 2004-03-17
US6420520B1 (en) 2002-07-16
BR9604843A (pt) 2002-02-19
CN1183785A (zh) 1998-06-03
DE69630948T2 (de) 2004-10-21
DE69630948D1 (de) 2004-01-15
KR19980703527A (ko) 1998-11-05
EP0821004A4 (de) 1998-08-12
AU5162196A (en) 1996-10-23
JP3398255B2 (ja) 2003-04-21

Similar Documents

Publication Publication Date Title
ATE176483T1 (de) Derivate des parathormons
HK1014191A1 (en) Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
CA2181150A1 (en) Biologically Active Peptides from Functional Domains of Bactericidal/Permeability-Increasing Protein and Uses Thereof
ATE334668T1 (de) Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
ATE301675T1 (de) Methode zur lösung, reinigung und rückfaltung von protein
ATE262336T1 (de) Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa- 4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14- dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen
DE69637104D1 (de) Heilmittel für arthrosis deformans und entzündliche gelenkerkrankungen
ATE162073T1 (de) Pharmazeutische zusammensetzung zur behandlung von osteoporose enthaltend xanthohumol
SE9801495D0 (sv) Protein formulationa
ATE337339T1 (de) Therapeutische verwendung von smr1 protein und seinen aktiven derivaten
ATE377026T1 (de) Behandlung von fettleibigkeit
DE69934110T8 (de) Monomeres mp52/gdf-5 mit knochenmorphogener aktivität, und dieses enthaltende arzneimittel, zur vorbeugung und behandlung von knochen- und knorpelerkrankungen
WO1998056398A3 (en) A method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon
ATE255593T1 (de) Peptide und medikamente für knochenkrankheiten welche diese peptide als aktive bestandteile beinhalten
HUP9901303A2 (hu) Gyógyszerkészítmény autoimmun betegségek kezelésére
PL336897A1 (en) Novel salts of bpc peptides, pharmaceutic compositions conatining them and method of obtaining such salts
ATE303401T1 (de) Fragmente des virus proteins 2 oder 3 des polyomavirus als fähren für wirkstoffe
RU95105249A (ru) Гидрохлорид ng монометил-l-аргинина, способы его получения, способ получения фармацевтического препарата и способ лечения
DK0826373T3 (da) Forebyggende middel mod postoperativ astigmatisme
KR950704358A (ko) 카텝신 l 특이적 저해 폴리펩티드
CA2216704A1 (en) Novel peptides and remedy for bone diseases containing the same as active ingredient
OA07802A (fr) Nouveau pesticide de synthèse, son procédé de préparation et médicaments le contenant.
AU7435298A (en) Compositions for enhancing immunosuppressants' pharmaceutical acti vities
DE69915852D1 (de) Lhrh-analoga zur behandlung der osteoporose
MX9604539A (es) Aminoacidos modificados para la distribucion de farmaco.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties